Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Free Report)’s share price was up 12,207.7% on Thursday . The stock traded as high as $0.6435 and last traded at $0.64. Approximately 1,553 shares traded hands during trading, a decline of 35% from the average daily volume of 2,381 shares. The stock had previously closed at $0.0052.
Ampio Pharmaceuticals Stock Performance
The company has a market capitalization of $726,400.00, a P/E ratio of -0.06 and a beta of 7.65. The stock’s fifty day moving average price is $0.19 and its 200-day moving average price is $0.11.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc is a clinical‐stage biopharmaceutical company focused on developing therapies that modulate the body’s inflammatory response to alleviate pain and improve functional outcomes. Headquartered in Englewood, Colorado, the company leverages proprietary plasma‐derived and synthetic formulations to target chronic musculoskeletal and cardiovascular conditions.
The company’s lead product candidate, Ampion, is a novel, low‐molecular‐weight fraction of human serum albumin designed as a single intra‐articular injection for patients suffering from osteoarthritis of the knee.
Featured Stories
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
